Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease

BACKGROUND: Plasma and cerebrospinal fluid levels of neurofilament light (NfL), a marker of axonal degeneration, have previously been reported to be raised in patients with clinically diagnosed Alzheimer’s disease (AD). Activated microglia, an intrinsic inflammatory response to brain lesions, are al...

Descripción completa

Detalles Bibliográficos
Autores principales: Parbo, Peter, Madsen, Lasse Stensvig, Ismail, Rola, Zetterberg, Henrik, Blennow, Kaj, Eskildsen, Simon F., Vorup-Jensen, Thomas, Brooks, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941285/
https://www.ncbi.nlm.nih.gov/pubmed/31898549
http://dx.doi.org/10.1186/s13195-019-0574-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941285/
https://www.ncbi.nlm.nih.gov/pubmed/31898549
http://dx.doi.org/10.1186/s13195-019-0574-0

Ejemplares similares